Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD

NCT ID: NCT02080936

Last Updated: 2014-03-07

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 138 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2014-01-31
• Study Completion Date: 2014-03-31

Brief Summary

Peripheral muscle mass and strength are relevant indicators of COPD survival. Current guidelines recommend to assess muscle strength only in muscle wasted patients. However, a recent study reported quadriceps weakness without muscle wasting (Menon, M et al. Resp. Res.2012, 13:119). Thus, these guidelines raise the risk to miss out some weak patients. In clinical settings, fat-free-mass index (FFMI) is indicated as a simple index to assess muscle wasting. We aimed at determining the prevalence of patients entering in pulmonary rehabilitation (PR) a priori not eligible for muscle strength evaluation given the lack of muscle wasting clinical signs.

Conditions

COPD

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Patients who have got FFMI (bioimpedance)
• Patients who have done quadriceps muscle strenght evaluation

Exclusion Criteria

• Patients without FFMI
• Patients without quadriceps muscle strenght

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

5 Santé

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Clinique du Souffle La Vallonie

Lodève, , France

Countries

France

Other Identifiers

FVIE_M2W

Identifier Type: -

Identifier Source: org_study_id